MedTrace Logo

PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy

NCT03392948 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1080

Last updated 2022-07-22

No results posted yet for this study

Summary

Approximately 5 to 8% of patients undergoing percutaneous coronary interventions requires chronic anticoagulant therapy due to atrial fibrillation or other clinical entities. There are many possible different combinations of the antithrombotic therapy after stent implantation in these patients.

Aim of this observational study is to evaluate the real world antithrombotic treatment in patients requiring anticoagulant therapy undergoing stent implantation and to compare the clinical outcome of patients treated with new oral anticoagulant drugs compared to warfarin.

The study is prospective, performed in different Italian hospitals and aimed to enroll 1080 patients with a 1 year follow up

Conditions

  • Acute Myocardial Infarction
  • Unstable Angina
  • Chronic Stable Angina

Sponsors & Collaborators

  • Italian Society of Invasive Cardiology

    lead OTHER

Principal Investigators

  • Alessandro Sciahbasi, MD · Ospedale Sandro Pertini, ASL RM2, Rome

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-09
Primary Completion
2022-02-28
Completion
2023-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03392948 on ClinicalTrials.gov